DOCSLIB.ORG

S. Nagel Et Al., Microarray Analysis of the Global Gene Expression Profile Following Hypothermia and Transient Focal Cerebral Ischemia Neuroscience 2012

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
S. Nagel Et Al., Microarray Analysis of the Global Gene Expression Profile Following Hypothermia and Transient Focal Cerebral Ischemia Neuroscience 2012 S. Nagel et al., Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia Neuroscience 2012 Supplementary Table 1 Gene Symbol Entrez Gene Name Affymetrix SNP ID Fold Change PEBP1 phosphatidylethanolamine binding protein 1 E05646cds_s_at 36,571 KIFC1 kinesin family member C1 AF035951_at 29,307 SERP1 stress-associated endoplasmic reticulum protein 1 AF100470_at 23,16 FDXR ferredoxin reductase D63761_g_at 22,504 SYNPO synaptopodin AB013130_at 21,174 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein L23148_g_at 16,233 GTF2F2 general transcription factor IIF, polypeptide 2, 30kDa L01267_at 15,592 PPP2R2C protein phosphatase 2, regulatory subunit B, gamma D38261_at 15,356 RASGRP1 RAS guanyl releasing protein 1 (calcium and DAG-regulated) AF081196_at 15,142 UBB -- D16554_at 14,996 SLC37A4 solute carrier family 37 (glucose-6-phosphate transporter), member 4 AF080468_g_at 14,757 LIMK2 LIM domain kinase 2 D31874_at 14,254 PPP1R15A protein phosphatase 1, regulatory (inhibitor) subunit 15A AF020618_g_at 13,988 HPCAL4 hippocalcin like 4 D13125_at 13,128 FAIM2 Fas apoptotic inhibitory molecule 2 AF044201_at 12,77 GJA5 gap junction protein, alpha 5, 40kDa AF022136_at 12,751 SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 D13962_g_at 12,245 TRIM23 tripartite motif containing 23 L04760_at 12,122 PIP4K2C phosphatidylinositol-5-phosphate 4-kinase, type II, gamma AF030558_at 11,698 SBK1 SH3-binding domain kinase 1 AB010154_at 11,523 PLEKHA1 pleckstrin homology domain containing, family A member 1 AF034237_s_at 11,161 MT-ND4 NADH dehydrogenase, subunit 4 (complex I) rc_AA859612_f_at 10,882 NF1 neurofibromin 1 D45201_at 10,663 AKT1 v-akt murine thymoma viral oncogene homolog 1 D30040_at 10,106 APLP2 amyloid beta (A4) precursor-like protein 2 M31322_g_at 9,862 LOC246267 resection-induced TPI (rs11) AF007890_at 9,431 GNG7 guanine nucleotide binding protein (G protein), gamma 7 L23219_at 9,361 ALDH6A1 aldehyde dehydrogenase 6 family, member A1 M93401_at 9,297 SLCO1A5 solute carrier organic anion transporter family, member 1a5 AF041105_at 9,165 FGF9 fibroblast growth factor 9 (glia-activating factor) D14839_at 9,138 SVIL supervillin rc_AA800735_at 8,828 CDC5L CDC5 cell division cycle 5-like (S. pombe) AF000578_at 8,727 BCKDHA branched chain keto acid dehydrogenase E1, alpha polypeptide J02827_at 8,671 MRPL3 mitochondrial ribosomal protein L3 rc_AA800272_at 8,24 ADM adrenomedullin D15069_s_at 8,075 GSTM1 glutathione S-transferase mu 1 rc_AA859372_s_at 8,034 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 AJ000347_g_at 8,024 GABBR1 gamma-aminobutyric acid (GABA) B receptor, 1 AB016161UTR#1_g_at 7,913 GIT1 G protein-coupled receptor kinase interacting ArfGAP 1 AF085693_at 7,895 NDRG2 NDRG family member 2 rc_AA799560_at 7,853 APBA2 amyloid beta (A4) precursor protein-binding, family A, member 2 AF029107_at 7,787 GAMT guanidinoacetate N-methyltransferase J03588_at 7,642 SCG5 secretogranin V (7B2 protein) M63901_at 7,497 PSMB9 proteasome (prosome, macropain) subunit, beta type, 9 D10757_at 7,411 CLIP2 CAP-GLY domain containing linker protein 2 AJ000485_at 7,295 PIGL phosphatidylinositol glycan anchor biosynthesis, class L D88364_at 7,212 CRIPT cysteine-rich PDZ-binding protein AF047384_at 7,052 SCN9A sodium channel, voltage-gated, type IX, alpha subunit AF000368_at 7,048 GABRD gamma-aminobutyric acid (GABA) A receptor, delta M35162_at 6,986 SF1 splicing factor 1 AF079873_at 6,986 HLA-C major histocompatibility complex, class I, C L40362_f_at 6,966 TNFRSF1A tumor necrosis factor receptor superfamily, member 1A M63122_at 6,894 PIK3CB phosphoinositide-3-kinase, catalytic, beta polypeptide AJ012482_at 6,622 AP4S1 adaptor-related protein complex 4, sigma 1 subunit rc_AA800277_at 6,596 GSTO1 glutathione S-transferase omega 1 AB008807_g_at 6,55 FCGR2A Fc fragment of IgG, low affinity IIa, receptor (CD32) M32062_g_at 6,457 JAK3 Janus kinase 3 D28508_at 6,418 CHRNA7 cholinergic receptor, nicotinic, alpha 7 L31619_at 6,385 NRGN neurogranin (protein kinase C substrate, RC3) L09119_at 6,338 PAFAH1B3 platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) AF016047_at 6,326 ALDOA aldolase A, fructose-bisphosphate M12919mRNA#2_g_at 6,316 SNF8 SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) rc_AA891666_g_at 6,284 LRRC59 leucine rich repeat containing 59 D13623_g_at 6,222 NR3C2 nuclear receptor subfamily 3, group C, member 2 M36074_g_at 6,198 MPP3 membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) AF087697_at 6,18 APC adenomatous polyposis coli L19306_s_at 6,098 ABAT 4-aminobutyrate aminotransferase D87839_g_at 5,971 IGFBP2 insulin-like growth factor binding protein 2, 36kDa M91595exon_s_at 5,936 CCDC92 coiled-coil domain containing 92 M91652complete_seq_g_at 5,931 STX7 syntaxin 7 AF031430_at 5,914 SLC12A2 solute carrier family 12 (sodium/potassium/chloride transporters), member 2 AF051561_s_at 5,812 Ndufs6 NADH dehydrogenase (ubiquinone) Fe-S protein 6 L38437_at 5,791 SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 J05035_at 5,701 MED1 mediator complex subunit 1 rc_AA800817_at 5,674 RHOJ ras homolog gene family, member J rc_AA858617_at 5,643 ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I D14909_at 5,589 ADAM17 ADAM metallopeptidase domain 17 AJ012603UTR#1_at 5,557 TRA2B transformer 2 beta homolog (Drosophila) D49708_at 5,508 HNRNPK heterogeneous nuclear ribonucleoprotein K D17711cds_s_at 5,495 SREBF1 sterol regulatory element binding transcription factor 1 L16995_at 5,452 RBBP7 retinoblastoma binding protein 7 AF090306_s_at 5,366 ANXA5 annexin A5 AF051895_at 5,327 LPAR1 lysophosphatidic acid receptor 1 rc_AA848831_at 5,313 PDHB pyruvate dehydrogenase (lipoamide) beta rc_AA892828_g_at 5,254 SLC4A1 solute carrier family 4, anion exchanger, member 1 J04793_at 5,218 PRKCE protein kinase C, epsilon M18331_g_at 5,211 TGFBR3 transforming growth factor, beta receptor III M80784_s_at 5,203 PPP1R10 protein phosphatase 1, regulatory (inhibitor) subunit 10 AF040954_at 5,192 BCKDHB branched chain keto acid dehydrogenase E1, beta polypeptide rc_AI168942_at 5,169 MEF2D myocyte enhancer factor 2D AJ005425_at 5,111 PPP2R2B protein phosphatase 2, regulatory subunit B, beta rc_AI103238_at 5,091 PTP4A1 -- L27843_s_at 4,966 GIPC1 GIPC PDZ domain containing family, member 1 AF089817_i_at 4,911 NUP62 nucleoporin 62kDa M62992_at 4,897 ACVR2B activin A receptor, type IIB M87067_at 4,845 UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) D10699_at 4,822 ACAA1 acetyl-CoA acyltransferase 1 J02749_g_at 4,809 EPN2 epsin 2 AF096269_at 4,778 FLNB filamin B, beta rc_AA892820_at 4,762 ADORA2B adenosine A2b receptor M91466_at 4,713 TRPC1 transient receptor potential cation channel, subfamily C, member 1 AF061266_g_at 4,696 RPS21 ribosomal protein S21 rc_AI178207_at 4,667 TUFM Tu translation elongation factor, mitochondrial rc_AA866234_at 4,624 GOLGB1 golgin B1 D25543_at 4,618 UBE2B ubiquitin-conjugating enzyme E2B rc_AA799612_at 4,609 KCNJ8 potassium inwardly-rectifying channel, subfamily J, member 8 D42145_at 4,552 LGALS8 lectin, galactoside-binding, soluble, 8 rc_AI232691_at 4,532 SOD1 superoxide dismutase 1, soluble M25157mRNA_i_at 4,53 NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa rc_AA851379_at 4,524 UBC ubiquitin C D17296_at 4,492 THY1 Thy-1 cell surface antigen rc_AA874848_s_at 4,481 CDH2 cadherin 2, type 1, N-cadherin (neuronal) AF097593_at 4,434 NRXN2 neurexin 2 M96376_at 4,381 PRKCB protein kinase C, beta E01789cds_s_at 4,381 GABRA4 gamma-aminobutyric acid (GABA) A receptor, alpha 4 L08493cds_s_at 4,345 CLU clusterin M64733mRNA_s_at 4,317 PARK7 Parkinson disease (autosomal recessive, early onset) 7 AJ007291_at 4,293 UBAC2 UBA domain containing 2 rc_AA874876_at 4,24 HSPA1B -- L16764_s_at 4,197 GSTA1 glutathione S-transferase alpha 1 K01932_f_at 4,194 TGFA transforming growth factor, alpha M31076_at 4,157 YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein rc_AA965154_at 4,126 PTPRC protein tyrosine phosphatase, receptor type, C M10072mRNA_s_at 4,094 MOBP myelin-associated oligodendrocyte basic protein D28111_at 4,068 ATP5S ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) rc_AA799829_at 4,054 PSMC1 proteasome (prosome, macropain) 26S subunit, ATPase, 1 D50696_at 4,045 ST8SIA1 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 D45255_s_at -8,344 DLGAP5 discs, large (Drosophila) homolog-associated protein 5 rc_AA874827_at -8,179 IFRD1 interferon-related developmental regulator 1 rc_AI014163_at -7,885 PLAGL1 pleiomorphic adenoma gene-like 1 rc_AA900750_s_at -7,688 HSP90AB1 heat shock protein 90kDa alpha (cytosolic), class B member 1 rc_AI008074_s_at -7,39 ST6GALNAC3 ST6 -N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 rc_AI231519_at -7,227 COL1A1 collagen, type I, alpha 1 rc_AI231472_s_at -6,899 MAS1 MAS1 oncogene rc_AI071498_at -6,594 RPP21 ribonuclease P/MRP 21kDa subunit rc_AA893905_g_at -6,03 UGT8 UDP glycosyltransferase 8 rc_AI228110_s_at -4,942 YBX1 Y box binding protein 1 rc_AI230572_at -4,851 PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 rc_AA800175_at -4,765 RPS26 ribosomal protein S26 rc_AI014087_at -4,731 GH1 growth hormone 1 J00739_at -4,678 MCM6 minichromosome maintenance complex component 6 rc_AI639082_s_at -4,678 GNPTG N-acetylglucosamine-1-phosphate transferase, gamma subunit rc_AA875171_g_at -4,546 HPCAL1 hippocalcin-like 1 D13126_at -4,531 MTHFD1 methylenetetrahydrofolate
Load more

Recommended publications
  • A New Michaelis Complex Leads to Efficient Transition State Charge Offset
    Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to efficient transition state charge offset Charlotte M. Mitona,1, Stefanie Jonasa,2, Gerhard Fischera,3, Fernanda Duarteb,3,4, Mark F. Mohameda, Bert van Looa,5, Bálint Kintsesa,6, Shina C. L. Kamerlinb, Nobuhiko Tokurikia,c, Marko Hyvönena, and Florian Hollfeldera,7 aDepartment of Biochemistry, University of Cambridge, CB2 1GA Cambridge, United Kingdom; bDepartment of Chemistry, Biomedicinskt Centrum (BMC), Uppsala University, 751 23 Uppsala, Sweden; and cMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada Edited by Daniel Herschlag, Stanford University, Stanford, CA, and accepted by Editorial Board Member Michael A. Marletta May 31, 2018 (received for review January 31, 2018) The recruitment and evolutionary optimization of promiscuous catalytic residues but also occurs at the periphery of the catalytic enzymes is key to the rapid adaptation of organisms to changing machinery, even in positions as remote as the second and third environments. Our understanding of the precise mechanisms shells of the active site (23). In studies examining detailed evo- underlying enzyme repurposing is, however, limited: What are lutionary transitions, function-altering mutations led to the dis- the active-site features that enable the molecular recognition of placement of a catalytic metal ion or the repositioning of a multiple substrates with contrasting catalytic requirements? To nucleophile (24–26). In further cases, the position of the catalytic gain insights into the molecular determinants of adaptation in residues remained unaltered, but other structural features, for promiscuous enzymes, we performed the laboratory evolution of an arylsulfatase to improve its initially weak phenylphosphonate Significance hydrolase activity.
    [Show full text]
  • 1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
    Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN.
    [Show full text]
  • Exploring the Microbiome of the Mediterranean Sponge Aplysina Aerophoba by Single-Cell and Metagenomics
    Exploring the microbiome of the Mediterranean sponge Aplysina aerophoba by single-cell and metagenomics Untersuchungen am Mikrobiom des Mittelmeerschwamms Aplysina aerophoba mittels Einzelzell- und Metagenomik Doctoral thesis for a doctoral degree at the Graduate School of Life Sciences Julius-Maximilians-Universität Würzburg Section: Integrative Biology Submitted by Beate Magdalena Slaby from München Würzburg, March 2017 Submitted on: ……………………………………………………… Members of the Promotionskomitee Chairperson: Prof. Dr. Thomas Müller Primary Supervisor: Prof. Dr. Ute Hentschel Humeida Supervisor (Second): Prof. Dr. Thomas Dandekar Supervisor (Third): Prof. Dr. Frédéric Partensky Date of public defense: ……………………………………………………… Date of receipt of certificates: ……………………………………………………… ii Affidavit I hereby confirm that my thesis entitled ‘Exploring the microbiome of the Mediterranean sponge Aplysina aerophoba by single-cell and metagenomics’ is the result of my own work. I did not receive any help or support from commercial consultants. All sources and / or materials applied are listed and specified in the thesis. Furthermore, I confirm that this thesis has not yet been submitted as part of another examination process neither in identical nor in similar form. Place, Date Signature iii Acknowledgements I received financial support for this thesis project by a grant of the German Excellence Initiative to the Graduate School of Life Sciences of the University of Würzburg through a PhD fellowship, and from the SponGES project that has received funding from the European Union’s Horizon 2020 research and innovation program. I would like to thank: Dr. Ute Hentschel Humeida for her support and encouragement, and for providing so many extraordinary opportunities. Dr. Thomas Dandekar and Dr. Frédéric Partensky for the supervision and a number of very helpful discussions.
    [Show full text]
  • N-Acetylgalactosamine-6-Sulfate Sulfatase in Man. Absence of the Enzyme in Morquio Disease
    N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Singh, … , P Niebes, D Tavella J Clin Invest. 1976;57(4):1036-1040. https://doi.org/10.1172/JCI108345. Research Article Human N-acetylgalactosamine-6-sulfate sulfatase (6-sulfatase) activity is measured by using as a substrate a sulfated tetrasaccharide obtained by digesting purified chondroitin-6-sulfate (C-6-S) with testicular hyaluronidase. The amount of inorganic sulfate released is measured turbidimetrically. The enzyme from human kidney has a pH optimum of 4.8; its activity is augmented by low levels of NaCl and inhibited by phosphate and high levels of NaCl. Free glucuronate, acetylgalactosamine, inorganic sulfate, polymeric C-6-S, or tetrasaccharide obtained from chondroitin-4-sulfate do not affect the enzyme activity. The method may be used for the diagnosis of Morquio disease since extracts of Morquio fibroblasts are devoid of 6-sulfatase activity. Find the latest version: https://jci.me/108345/pdf N-Acetylgalactosamine-6-Sulfate Sulfatase in Man ABSENCE OF THE ENZYME IN MORQUIO DISEASE JAGAT SINGH, NICOLA Di FERRANTE, PAUL NIEBES, and DANIELA TAVELLA From the Departments of Biochemistry and Medicine, and the Division of Orthopedic Surgery of the Department of Surgery, Baylor College of Medicine, Houston, Texas 77025 and Zyma, S.A., Nyon, Switzerland A B S T R A C T Human N-acetylgalactosamine-6-sulfate measurement, and the need to ascertain whether the sulfatase (6-sulfatase) activity is measured by using as sulfate released was in position 4 or 6 of the galactos- a substrate a sulfated tetrasaccharide obtained by di- amine moieties make the method (1) rather laborious gesting purified chondroitin-6-sulfate (C-6-S) with tes- and not ideal for the routine assay of the enzyme ac- ticular hyaluronidase.
    [Show full text]
  • Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
    Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................
    [Show full text]
  • Lab Dept: Chemistry Test Name: ARYLSULFATASE A, LEUKOCYTES
    Lab Dept: Chemistry Test Name: ARYLSULFATASE A, LEUKOCYTES General Information Lab Order Codes: ARYL Synonyms: Metachromic Leukodystrophy; Mucolipidoses, Types II and III; ARS-A (Arylsulfatase A); WBC Aryl Sulfatase A CPT Codes: 82657 – Enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; nonradioactive substrate Test Includes: Arylsulfatase A, Leukocyte level reported in nmol/h/mg. Logistics Test Indications: Leukocyte assay is the preferred test to order first to rule out metachromatic leukodystrophy. Not reliable in identifying carriers due both to analytical variation and unusual genetic variants. The urine assay should be used in confirming leukocyte results. Lab Testing Sections: Chemistry - Sendouts Referred to: Mayo Medical Laboratories (MML Test: ARSAW) Phone Numbers: MIN Lab: 612-813-6280 STP Lab: 651-220-6550 Test Availability: Daily, 24 hours (Specimen must be received by reference lab within 96 hours of collection and must be received 1 day prior to assay day for processing) Turnaround Time: 8 – 15 days; test set up Tuesday Special Instructions: Specimen must arrive within 48 hours of draw. Obtain special collection tube from the laboratory. Specimen Specimen Type: Whole blood Container: Yellow top (ACD Solution B) tube available from laboratory Alternate: Yellow top (ACD Solution A) Draw Volume: 6 mL (Minimum: 5 mL) ACD Whole blood Processed Volume: Same as Draw Volume Collection: Routine blood collection Special Processing: Lab Staff: Do Not process specimen, leave in original draw container.
    [Show full text]
  • Structural and Mechanistic Analysis of the Choline Sulfatase from Sinorhizobium Melliloti: a Class I Sulfatase Specific for an Alkyl Sulfate Ester
    Article Structural and Mechanistic Analysis of the Choline Sulfatase from Sinorhizobium melliloti: A Class I Sulfatase Specific for an Alkyl Sulfate Ester Bert van Loo 1,2, Markus Schober 1,3,†, Eugene Valkov 1,‡, Magdalena Heberlein 2, Erich Bornberg-Bauer 2, Kurt Faber 3, Marko Hyvönen 1 and Florian Hollfelder 1 1 - Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom 2 - Institute for Evolution and Biodiversity, University of Münster, Hüfferstrasse 1, D-48149 Münster, Germany 3 - Department of Chemistry, Organic & Bioorganic Chemistry, University of Graz, Heinrichstrasse 28, A-8010 Graz, Austria Correspondence to Marko Hyvönen and Florian Hollfelder:. [email protected]; [email protected]. https://doi.org/10.1016/j.jmb.2018.02.010 Edited by Thomas J. Smith Abstract Hydrolysis of organic sulfate esters proceeds by two distinct mechanisms, water attacking at either sulfur (S–O bond cleavage) or carbon (C–O bond cleavage). In primary and secondary alkyl sulfates, attack at carbon is favored, whereas in aromatic sulfates and sulfated sugars, attack at sulfur is preferred. This mechanistic distinction is mirrored in the classification of enzymes that catalyze sulfate ester hydrolysis: arylsulfatases (ASs) catalyze S–O cleavage in sulfate sugars and arylsulfates, and alkyl sulfatases break the C–O bond of alkyl sulfates. Sinorhizobium meliloti choline sulfatase (SmCS) efficiently catalyzes the 3 −1 −1 hydrolysis of alkyl sulfate choline-O-sulfate (kcat/KM = 4.8 × 10 s M ) as well as arylsulfate 4-nitrophenyl −1 −1 sulfate (kcat/KM =12s M ). Its 2.8-Å resolution X-ray structure shows a buried, largely hydrophobic active site in which a conserved glutamate (Glu386) plays a role in recognition of the quaternary ammonium group of the choline substrate.
    [Show full text]
  • Hatzios Thesis Formatted
    Investigations of Metabolic Pathways in Mycobacterium tuberculosis by Stavroula K Hatzios A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Carolyn R. Bertozzi, Chair Professor Matthew B. Francis Professor Tom Alber Fall 2010 Investigations of Metabolic Pathways in Mycobacterium tuberculosis © 2010 By Stavroula K Hatzios Abstract Investigations of Metabolic Pathways in Mycobacterium tuberculosis by Stavroula K Hatzios Doctor of Philosophy in Chemistry University of California, Berkeley Professor Carolyn R. Bertozzi, Chair Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis in humans, infects roughly two billion people worldwide. However, less than one percent of infected individuals are symptomatic. Most have a latent infection characterized by dormant, non- replicating bacteria that persist within a mass of immune cells in the lung called the granuloma. The granuloma provides a protective barrier between infected cells and surrounding tissue. When host immunity is compromised, the granuloma can deteriorate and reactivate the disease. In order to mount a latent infection, Mtb must survive in alveolar macrophages, the host’s primary line of defense against this intracellular pathogen. By evading typical bactericidal processes, Mtb is able to replicate and stimulate granuloma formation. The mechanisms by which Mtb persists in macrophages are ill defined; thus, elucidating the factors responsible for this hallmark of Mtb pathogenesis is an important area of research. This thesis explores three discrete metabolic pathways in Mtb that are likely to mediate its interactions with host immune cells. The first three chapters examine the sulfate assimilation pathway of Mtb and its regulation by the phosphatase CysQ.
    [Show full text]
  • A Marine Bacterial Enzymatic Cascade Degrades the Algal Polysaccharide
    A marine bacterial enzymatic cascade degrades the algal polysaccharide ulvan Lukas Reisky, Aurelie Prechoux, Marie-Katherin Zühlke, Marcus Bäumgen, Craig Robb, Nadine Gerlach, Thomas Roret, Christian Stanetty, Robert Larocque, Gurvan Michel, et al. To cite this version: Lukas Reisky, Aurelie Prechoux, Marie-Katherin Zühlke, Marcus Bäumgen, Craig Robb, et al.. A marine bacterial enzymatic cascade degrades the algal polysaccharide ulvan. Nature Chemical Biology, Nature Publishing Group, 2019, 15 (8), pp.803-812. 10.1038/s41589-019-0311-9. hal-02347779 HAL Id: hal-02347779 https://hal.archives-ouvertes.fr/hal-02347779 Submitted on 5 Nov 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 A marine bacterial enzymatic cascade degrades the algal polysaccharide ulvan 2 Lukas Reisky,1# Aurélie Préchoux,2# Marie-Katherin Zühlke,3,4# Marcus Bäumgen,1 Craig S. 3 Robb,5,6 Nadine Gerlach,5,6 Thomas Roret,7 Christian Stanetty,8 Robert Larocque,7 Gurvan 4 Michel,2 Song Tao,5,6 Stephanie Markert,3,4 Frank Unfried,3,4 Marko D. Mihovilovic,8 Anke 5 Trautwein-Schult,9
    [Show full text]
  • Diagnosis and Treatment of Multiple Sulfatase Deficiency and Others Using a Formylglycine Generating Enzyme (FGE)
    (19) & (11) EP 2 325 302 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 25.05.2011 Bulletin 2011/21 C12N 9/02 (2006.01) C12N 15/52 (2006.01) C12Q 1/68 (2006.01) A61K 38/36 (2006.01) (2006.01) (2006.01) (21) Application number: 10182644.4 A61K 38/44 A61K 31/7088 G01N 33/68 (2006.01) (22) Date of filing: 10.02.2004 (84) Designated Contracting States: • Dierks, Thomas AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 33613 Bielefeld (DE) HU IE IT LI LU MC NL PT RO SE SI SK TR • Heartlein, Michael W Boxborough, MA 01719 (US) (30) Priority: 11.02.2003 US 447747 P • Ballabio, Andrea, Dr. 80122 Napoli (IT) (62) Document number(s) of the earlier application(s) in • Cosma, Maria Pia accordance with Art. 76 EPC: 1-80134 Naples (IT) 04709824.9 / 1 592 786 (74) Representative: White, Martin Paul (71) Applicant: Shire Human Genetic Therapies, Inc. Patents Designs & Brands Ltd. Cambridge, MA 02139 (US) 211 The Colonnades Liverpool (72) Inventors: L3 4AB (GB) • Von Figura, Kurt 37085 Göttingen (DE) Remarks: • Schmidt, Bernhard This application was filed on 29-09-2010 as a 37073 Göttingen (DE) divisional application to the application mentioned under INID code 62. (54) Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE) (57) This invention relates to methods and composi- tions for the diagnosis and treatment of Multiple Sulfatase Deficiency (MSD) as well as other sulfatase deficiencies. More specifically, the invention relates to isolated mole- cules that modulate post-translational modifications on sulfatases.
    [Show full text]
  • Somamer Reagents Generated to Human Proteins Number Somamer Seqid Analyte Name Uniprot ID 1 5227-60
    SOMAmer Reagents Generated to Human Proteins The exact content of any pre-specified menu offered by SomaLogic may be altered on an ongoing basis, including the addition of SOMAmer reagents as they are created, and the removal of others if deemed necessary, as we continue to improve the performance of the SOMAscan assay. However, the client will know the exact content at the time of study contracting. SomaLogic reserves the right to alter the menu at any time in its sole discretion. Number SOMAmer SeqID Analyte Name UniProt ID 1 5227-60 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Q15118 2 14156-33 14-3-3 protein beta/alpha P31946 3 14157-21 14-3-3 protein epsilon P62258 P31946, P62258, P61981, Q04917, 4 4179-57 14-3-3 protein family P27348, P63104, P31947 5 4829-43 14-3-3 protein sigma P31947 6 7625-27 14-3-3 protein theta P27348 7 5858-6 14-3-3 protein zeta/delta P63104 8 4995-16 15-hydroxyprostaglandin dehydrogenase [NAD(+)] P15428 9 4563-61 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 P19174 10 10361-25 2'-5'-oligoadenylate synthase 1 P00973 11 3898-5 26S proteasome non-ATPase regulatory subunit 7 P51665 12 5230-99 3-hydroxy-3-methylglutaryl-coenzyme A reductase P04035 13 4217-49 3-hydroxyacyl-CoA dehydrogenase type-2 Q99714 14 5861-78 3-hydroxyanthranilate 3,4-dioxygenase P46952 15 4693-72 3-hydroxyisobutyrate dehydrogenase, mitochondrial P31937 16 4460-8 3-phosphoinositide-dependent protein kinase 1 O15530 17 5026-66 40S ribosomal protein S3 P23396 18 5484-63 40S ribosomal protein
    [Show full text]
  • Kidney V-Atpase-Rich Cell Proteome Database
    A comprehensive list of the proteins that are expressed in V-ATPase-rich cells harvested from the kidneys based on the isolation by enzymatic digestion and fluorescence-activated cell sorting (FACS) from transgenic B1-EGFP mice, which express EGFP under the control of the promoter of the V-ATPase-B1 subunit. In these mice, type A and B intercalated cells and connecting segment principal cells of the kidney express EGFP. The protein identification was performed by LC-MS/MS using an LTQ tandem mass spectrometer (Thermo Fisher Scientific). For questions or comments please contact Sylvie Breton ([email protected]) or Mark A. Knepper ([email protected]).
    [Show full text]